Reversible electrocardiogram changes and cardiomyopathy secondary to baclofen withdrawal syndrome

American Heart Hospital Journal

Volumn 8, Issue 1, 2010, Pages 52-54

  Kireyev, Dmitriy ^a   Poh, Kian Keong ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; CREATINE KINASE; MIDAZOLAM; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; CENTRAL MUSCLE RELAXANT;

ADULT; ARTERIAL GAS; ARTICLE; BACLOFEN WITHDRAWAL SYNDROME; BLOOD CARBON DIOXIDE TENSION; BLOOD PRESSURE FLUCTUATION; BRADYCARDIA; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DYSPNEA; ELECTROCARDIOGRAM; FEVER; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MURMUR; HEART RATE; HUMAN; HYPOKINESIA; INTUBATION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LUNG ARTERY PRESSURE; MALE; MUSCLE SPASM; OXYGEN SATURATION; PRIORITY JOURNAL; QUADRIPLEGIA; RESUSCITATION; SEDATION; SINUS BRADYCARDIA; SINUS TACHYCARDIA; TACHYCARDIA; TELEMETRY; WITHDRAWAL SYNDROME; YOUNG ADULT; AUTONOMIC DYSREFLEXIA; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART BUNDLE BRANCH BLOCK; INSTRUMENTATION; METHODOLOGY; SPASTICITY; SYNDROME; TAKOTSUBO CARDIOMYOPATHY;

ADULT; AUTONOMIC DYSREFLEXIA; BACLOFEN; BUNDLE-BRANCH BLOCK; ELECTROCARDIOGRAPHY; FEVER; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; SUBSTANCE WITHDRAWAL SYNDROME; SYNDROME; TACHYCARDIA, SINUS; TAKOTSUBO CARDIOMYOPATHY;

EID: 79955648171     PISSN: 15419215     EISSN: 17517168     Source Type: Journal    
DOI: 10.15420/ahhj.2010.8.1.52     Document Type: Article

References (13)

1. Mohammed I, Hussain A. Intrathecal Baclofen withdrawal syndrome-a life-threatening complication of Baclofen pump: a case report, BMC Clin Pharmacol, 2004;4:6
2. Sampathkumar P, Scanlon PD, Plevak DJ. Baclofen withdrawal presenting as multiorgan system failure, Anesth Analg, 1998;87:562-3
3. Yan A T, Yan RT, Kennely BM, et al. Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes, Am Heart J, 2007;154:71-8
4. Zhong-qun Z, Wei W, Chong-quan Q, et al. Acute anterior wall myocardial infarction entailing ST-segment elevation in lead V3R, V1 or aVR: electrocardiographic and angiographic correlations, J Electrocardiol, 2008;41(4):329-34
5. Rostoff P, Latacz P, Piwowarska W, et al. Transient ST-segment elevation in lead aVR associated with tako-tsubo cardiomyopathy, Int J Cardiol, 2009;134(3):e97-e100
6. Martin GS, Mannino DM, Eaton S, et al. The Epidemiology of Sepsis in the United States from 1979 through 2000, N Engl J Med, 2003;348:1546-54
7. Muller-Werdan U, Buerke M, Ebelt H, et al. Septic Cardiomyopathy-A not yet discovered cardiomyopathy?, Exp Clin Cardiol, 2006;11(3): 226-36
8. Flierl MA, Rittirsch D, Huber-Lang MS, et al. Molecular events in the cardiomyopathy of sepsis, Mol Med, 2008;14:327-36
9. Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock, Ann Intern Med, 1984;100(4):483-90
10. Pizon AF, LoVecchio F. Reversible cardiomyopathy complicating intrathecal Baclofen withdrawal: A case report, J Med Toxicol, 2007;3(4):187-9
11. Sallerin-Caute B, Lazorthes Y, Monsarrat B, et al. Baclofen levels after intrathecal administration in severe spasticity, Eur J Clin Pharmacol, 1991;40:363-5
12. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome, Arch Phys Med Rehabil, 2002;83(6): 735-41
13. Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal, Aneth Analg, 1995;80:1054-6